| Naslov: | An LC-MS/MS method for quantification of lamotrigine and its main metabolite in dried blood spots |
|---|
| Avtorji: | ID Milosheska, Daniela (Avtor)
ID Roškar, Robert (Avtor)
ID Vovk, Tomaž (Avtor)
ID Lorber, Bogdan (Avtor)
ID Grabnar, Iztok (Avtor)
ID Trontelj, Jurij (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (2,87 MB)
MD5: CA6DA12A4BC76D6FD2F8E3C8F133899F
 URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1424-8247/17/4/449
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | Background: The antiepileptic drug lamotrigine (LTG) shows high pharmacokinetic variability due to genotype influence and concomitant use of glucuronidation inducers and inhibitors, both of which may be frequently taken by elderly patients. Our goal was to develop a reliable quantification method for lamotrigine and its main glucuronide metabolite lamotrigine-N2-glucuronide (LTG-N2-GLU) in dried blood spots (DBS) to enable routine therapeutic drug monitoring and to identify altered metabolic activity for early detection of drug interactions possibly leading to suboptimal drug response. Results: The analytical method was validated in terms of selectivity, accuracy, precision, matrix effects, haematocrit, blood spot volume influence, and stability. It was applied to a clinical study, and the DBS results were compared to the concentrations determined in plasma samples. A good correlation was established for both analytes in DBS and plasma samples, taking into account the haematocrit and blood cell-to-plasma partition coefficients. It was demonstrated that the method is suitable for the determination of the metabolite-to-parent ratio to reveal the metabolic status of individual patients. Conclusions: The clinical validation performed confirmed that the DBS technique is a reliable alternative for plasma lamotrigine and its glucuronide determination. |
|---|
| Ključne besede: | dried blood spot, lamotrigine, lamotrigine glucuronide, therapeutic drug monitoring, clinical validation, haematocrit effect |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2024 |
|---|
| Št. strani: | 16 str. |
|---|
| Številčenje: | Vol. 17, no. 4, [Article no.] 449 |
|---|
| PID: | 20.500.12556/DiRROS-30161  |
|---|
| UDK: | 615.015:616.853 |
|---|
| ISSN pri članku: | 1424-8247 |
|---|
| DOI: | 10.3390/ph17040449 |
|---|
| COBISS.SI-ID: | 191424771 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 4. 4. 2024;
|
|---|
| Datum objave v DiRROS: | 16.06.2026 |
|---|
| Število ogledov: | 39 |
|---|
| Število prenosov: | 15 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
